Amiodarone in COVID-19: let's not forget its potential for pulmonary toxicity

Chia Siang Kow, Syed Shahzad Hasan

Research output: Contribution to journalLetterpeer-review

Abstract

Aimo et al.1 presented an elegant review of the antiviral mechanism of amiodarone, which is a commonly used antiarrhythmic drug. Although in vitro experiments demonstrated the ability of amiodarone to inhibit coronavirus, we are still wary of the authors’ recommendation to evaluate amiodarone for the treatment of coronavirus disease 2019 (COVID-19) in clinical trials.
Original languageEnglish
Article numberzwa0086
Number of pages1
JournalEuropean Journal of Preventive Cardiology
DOIs
Publication statusE-pub ahead of print - 12 Nov 2020

Fingerprint

Dive into the research topics of 'Amiodarone in COVID-19: let's not forget its potential for pulmonary toxicity'. Together they form a unique fingerprint.

Cite this